MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, OPRX had -$3,196K decrease in cash & cash equivalents over the period. -$488K in free cash flow.

Cash Flow Overview

Change in Cash
-$3,196K
Free Cash flow
-$488K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Accounts receivable
    • Stock-based compensation
    • Accounts payable
    • Others
Negative Cash Flow Breakdown
    • Accrued expenses and other liabi...
    • Repayment of long-term debt
    • Revenue share payable
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Goodwill impairment
--0 -
Impairment charges
-368 --
Bad debt expense
-0 0 0
Net loss
-495 5,020 779 -667
Depreciation and amortization
1,064 1,078 1,081 2,168
Stock-based compensation
1,828 1,960 1,956 3,046
Amortization of debt issuance costs
358 325 174 611
Accounts receivable
-5,763 5,525 -1,285 -4,700
Prepaid expenses and other assets
290 19 -510 958
Accounts payable
1,430 -401 55 -174
Revenue share payable
-2,131 757 -262 -2,462
Accrued expenses and other liabilities
-7,989 1,461 -2,225 4,138
Operating lease liabilities
-2 -3 6 9
Taxes receivable and payable
-119 995 -1,101 -964
Deferred tax liabilities, net
50 -1,214 -1,033 1,033
Deferred loan fees
-250 --
Deferred revenue
166 108 -89 11
Net cash (used in) provided by operating activities
-467 7,088 3,202 8,425
Purchases of property and equipment
21 11 10 37
Capitalized software development costs
0 35 0 91
Net cash used in investing activities
-21 206 -10 -128
Cash paid for employee withholding taxes related to the vesting of restricted stock units
-962 188 -
Proceeds from exercise of stock options, net of cash paid for withholding taxes
-14 338 -
Cash paid for employee withholding taxes related to the vesting of restricted stock units
-75 --92
Repayment of long-term debt
2,691 2,500 500 5,000
Net cash used in financing activities
-2,708 -3,448 -258 -5,092
Net (decrease) increase in cash and cash equivalents
-3,196 3,846 2,934 3,205
Cash and cash equivalents - beginning of period
23,365 19,519 13,380 -
Cash and cash equivalents - end of period
20,169 23,365 19,519 -
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net (decrease)increase in cash and cash...-$3,196K Accounts receivable-$5,763K Stock-based compensation$1,828K Accounts payable$1,430K Depreciation andamortization$1,064K Amortization of debt issuancecosts$358K Deferred revenue$166K Net cash used infinancing activities-$2,708K Net cash (used in)provided by operating...-$467K Net cash used ininvesting activities-$21K Canceled cashflow$10,609K Repayment of long-termdebt$2,691K Accrued expenses andother liabilities-$7,989K Purchases of property andequipment$21K Revenue share payable-$2,131K Net loss-$495K Prepaid expenses andother assets$290K Taxes receivable andpayable-$119K Deferred taxliabilities, net$50K Operating leaseliabilities-$2K

OptimizeRx Corp (OPRX)

OptimizeRx Corp (OPRX)